Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tunnel widening after ACL reconstruction with different fixation techniques: aperture fixation with biodegradable interference screws versus all-inside technique with suspensory cortical buttons. 5-year data from a prospective randomized trial.
Eichinger M, Ploner M, Degenhart G, Rudisch A, Smekal V, Attal R, Mayr R. Eichinger M, et al. Among authors: mayr r. Arch Orthop Trauma Surg. 2023 Nov;143(11):6707-6718. doi: 10.1007/s00402-023-05001-x. Epub 2023 Aug 5. Arch Orthop Trauma Surg. 2023. PMID: 37542556 Free PMC article.
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
Pichler R, Fritz J, Maier S, Hassler MR, Krauter J, D Andrea D, Laukhtina E, Gust K, Mori K, Tully KH, Niedersuess-Beke D, Korber L, Spiegelberg JA, Bauernhofer T, Subiela JD, Mayr R, Kronbichler A, Moschini M, Teoh J, Pradere B, Shariat SF, Ulmer H, Mertens LS; European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Pichler R, et al. Among authors: mayr r. Cancer Immunol Immunother. 2024 Dec 21;74(1):30. doi: 10.1007/s00262-024-03871-7. Cancer Immunol Immunother. 2024. PMID: 39708183 Free PMC article.
Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative Study.
Rinderknecht E, von Winning D, Kravchuk A, Schäfer C, Schnabel MJ, Siepmann S, Mayr R, Grassinger J, Goßler C, Pohl F, Siska PJ, Zeman F, Breyer J, Schmelzer A, Gilfrich C, Brookman-May SD, Burger M, Haas M, May M. Rinderknecht E, et al. Among authors: mayr r. Curr Oncol. 2024 Nov 11;31(11):7061-7073. doi: 10.3390/curroncol31110520. Curr Oncol. 2024. PMID: 39590151 Free PMC article.
Impact of sarcopenia and fat distribution on outcomes in penile cancer.
Hartmann V, Engelmann SU, Pickl C, Haas M, Kälble S, Goßler C, Eckl C, Hofmann A, Pichler R, Burger M, Mayr R. Hartmann V, et al. Among authors: mayr r. Sci Rep. 2024 Oct 25;14(1):25422. doi: 10.1038/s41598-024-73602-6. Sci Rep. 2024. PMID: 39455610 Free PMC article.
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients.
Stojanović Gužvić N, Lüke F, Treitschke S, Coluccio A, Hoffmann M, Feliciello G, Varadarajan AR, Lu X, Weidele K, Botteron C, Materna-Reichelt S, Keil F, Evert K, Weber F, Schamberger T, Althammer M, Grosse J, Hellwig D, Schulz C, Seitz S, Ugocsai P, Schlenska-Lange A, Mayr R, Kaiser U, Dietmaier W, Polzer B, Warfsmann J, Honarnejad K, Pukrop T, Heudobler D, Klein CA, Werno C. Stojanović Gužvić N, et al. Among authors: mayr r. Mol Oncol. 2024 Oct 5. doi: 10.1002/1878-0261.13741. Online ahead of print. Mol Oncol. 2024. PMID: 39367702 Free article.
204 results